COMPANY

CNS Pharmaceuticals

Location: Houston, TX · source · Oct 2, 2026

Profile checked Oct 10, 2026

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2026-05-19 Raise Private raise (SEC Form D): $22.5M sold; issuer “CNS Pharmaceuticals, Inc.”. Verified from the SEC filing. SEC filing ↗

SEC Form D raise Raised $22.53M (Form D filed May 19, 2026). SEC Form D 0001683168-26-004126 (May 19, 2026)
Evidence (1 event)
- May 19, 2026 · SEC Form D 0001683168-26-004126
  Name of Issuer: CNS Pharmaceuticals, Inc.; CIK: 1729427; Address: Houston, TX; Submission type: D; Filing date: 2026-05-19; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-04; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 22525000; Total Amount Sold: 22525000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals